ProShare Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

ProShare Advisors’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-10,384	Closed	-$291K	–	2292
2014 Q3	$291K	Sell	10,384 -2,562	-20%	-$78K	﹤0.01%	1741
2014 Q2	$391K	Sell	12,946 -12,333	-49%	-$340K	0.01%	1749
2014 Q1	$700K	Buy	+25,279	New	+$661K	0.01%	1599
2013 Q4	–	Sell	-15,980	Closed	-$477K	–	2336
2013 Q3	$477K	Sell	15,980 -980	-6%	-$27.3K	0.01%	1512
2013 Q2	$488K	Buy	+16,960	New	+$467K	0.01%	1343

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

MRM

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ProShare Advisors's BRLI Position: Q4 2014 in Review

ProShare Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q4 2014, closing a stake of 10,384 shares — an estimated $291K sold.

ProShare Advisors first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $700K in Q1 2014. 182 funds tracked by Wall St. Rank hold BRLI as of Q4 2014.

ProShare Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q4 2014 after selling out during the quarter.
ProShare Advisors sold 10,384 BIO-REFERENCE LABS INC-NEW- shares in Q4 2014, an estimated $291K.
ProShare Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
ProShare Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $700K in Q1 2014.
182 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q4 2014.

Based on ProShare Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.